[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置：首页 > 精选文章

International Journal of Clinical Research. 2025; 9: (2) ; 10.12208/j.ijcr.20250083 .

Clinical study on the combination of Xiao'er Chaigui Antipyretic Oral Liquid and Oseltamivir in the treatment of pediatric influenza A
小儿柴桂退热口服液联合奥司他韦治疗小儿甲型流感临床研究

作者： 杜徽 *, 何海燕

定西市第二人民医院 甘肃定西

*通讯作者： 杜徽,单位：定西市第二人民医院 甘肃定西；

引用本文: 杜徽, 何海燕 小儿柴桂退热口服液联合奥司他韦治疗小儿甲型流感临床研究[J]. 国际临床研究杂志, 2025; 9: (2) : 93-96.
Published: 2025/2/13 16:17:01

摘要

目的 探究小儿甲型流感治疗中，小儿柴桂退热口服液与奥司他韦联合应用的临床效应研究。方法在本文将200例小儿甲型流感患儿作为研究对象，收治时间在2023年3月-2023年5月之间，随机分组为两组（每组100例患儿）。结果 观察组患儿治疗总有效率经过治疗后，观察组患儿Hs-CRP低于对照组（P＜0.05）；观察组发热持续时间、咽喉肿痛持续时间（均短于对照组的持续时间（P＜0.05）；观察组患儿不良反应发生率2.00%低于对照组（P＜0.05）。结论 小儿甲型流感治疗中，联合应用小儿柴桂退热口服液与奥司他韦，其临床成效尤为突出，能够促进病情早期恢复。

关键词： 小儿柴桂退热口服液；奥司他韦；小儿甲型流感

Abstract

Objective To investigate the clinical study of the combination of Xiao'er Chaigui Antipyretic Oral Liquid and Oseltamivir in the treatment of pediatric influenza A.
Methods In this study, 200 pediatric patients with influenza A were selected as the research subjects. They were admitted between March 2023 and May 2023 and randomly divided into two groups (100 patients in each group).
Results After treatment, the total effective rate of Hs CRP in the observation group was lower than that in the control group (P<0.05); The duration of fever and sore throat in the observation group were shorter than those in the control group (P<0.05); The incidence of adverse reactions in the observation group was 2.00% lower than that in the control group (P<0.05).
Conclusion   The combination of Xiao'er Chaigui Antipyretic Oral Liquid and Oseltamivir is highly effective in treating pediatric influenza A, promoting early recovery of the condition.

Key words： Xiao'er Chaigui Antipyretic Oral Liquid; Oseltamivir; Pediatric influenza A

参考文献 References

[1] 范世珍,于波海. 动态监测CRP、SAA和IL-6在儿童甲型流感诊断和治疗中的价值[J]. 中国实验诊断学,2021, 25(1): 9-12. 

[2] 樊红波,郭晶,李俊生,等. 奥司他韦治疗甲型流感的临床研究进展[J]. 中国医院用药评价与分析,2021,21(3):381-384. 

[3] 时晓光. 帕拉米韦与奥司他韦治疗儿童甲型流感的临床效果对比[J]. 中国保健营养,2021,31(2):174.

[4] 叶国秀,周宝琴,马健,等. 连花清瘟颗粒联合磷酸奥司他韦治疗小儿甲型流感的临床疗效[J]. 临床合理用药杂志, 2021,14(34):129-130. 

[5] 王振华,杨晓莉. 连花清瘟胶囊联合奥司他韦治疗甲型流感对患儿免疫水平的影响分析[J]. 医学理论与实践,2021,34(12):2058-2060. 

[6] STOWE, JULIA, TESSIER, ELISE, ZHAO, H., et al. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design[J]. International Journal of Epidemiology: Official Journal of the International Epidemiological Association, 2021,50(4):1124-1133. 

[7] 陈丽娟,蒋文钧,申晋,等. 五虎合剂联合磷酸奥司他韦治疗甲型流感样发热聚集性患儿的临床效果[J]. 中国医药科学,2021,11(23):13-15,77. 

[8] 刘涛,范红. 重症甲型流感诱发急性肺损伤的可能机制及治疗进展[J]. 华西医学,2021,36(1):1-7. 

[9] 赵结换,钟健仍,李娟红. 天茅抗毒液联合奥司他韦治疗甲型流感病毒感染的效果观察[J]. 广东医科大学学报,2021, 39(5):571-574. 

[10] 李琛,戴晨希,姜春雷,等. 银翘解毒颗粒联合阿比多尔治疗甲型流感的疗效及对炎症介质的影响[J]. 现代药物与临床,2021,36(7):1484-1487.